Odyssey Health Statistics
Total Valuation
Odyssey Health has a market cap or net worth of 831,820. The enterprise value is 3.78 million.
| Market Cap | 831,820 |
| Enterprise Value | 3.78M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Odyssey Health has 110.22 million shares outstanding. The number of shares has increased by 3.45% in one year.
| Current Share Class | 110.22M |
| Shares Outstanding | 110.22M |
| Shares Change (YoY) | +3.45% |
| Shares Change (QoQ) | -40.33% |
| Owned by Insiders (%) | 14.37% |
| Owned by Institutions (%) | n/a |
| Float | 94.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.58 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -577.60% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 7.53% |
| Weighted Average Cost of Capital (WACC) | 31.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.86M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.52% in the last 52 weeks. The beta is -1.47, so Odyssey Health's price volatility has been lower than the market average.
| Beta (5Y) | -1.47 |
| 52-Week Price Change | -89.52% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 44.75 |
| Average Volume (20 Days) | 125,470 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -912,994 |
| Pretax Income | -5.73M |
| Net Income | -5.73M |
| EBITDA | n/a |
| EBIT | -912,994 |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 122,361 in cash and 3.07 million in debt, with a net cash position of -2.94 million or -0.03 per share.
| Cash & Cash Equivalents | 122,361 |
| Total Debt | 3.07M |
| Net Cash | -2.94M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -12.13M |
| Book Value Per Share | -0.11 |
| Working Capital | -12.13M |
Cash Flow
| Operating Cash Flow | -1.05M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.17M |
| Free Cash Flow | -1.05M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Odyssey Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.45% |
| Shareholder Yield | -3.45% |
| Earnings Yield | -700.86% |
| FCF Yield | -126.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |